Clinical trials data
Digit Span Test in cognitive impairment and decline trials: 60 registered studies
Every registered cognitive impairment and decline study on ClinicalTrials.gov that names the Digit Span Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered cognitive impairment and decline studies name it in an outcome measure
- 60
- Name it in a primary outcome, 48%
- 29 of 60
Tests named in the same studies
- 1
Verbal Learning27 studies, 16 as a primary outcome
- 2
Trail Making Test25 studies, 11 as a primary outcome
- 3
Verbal Fluency17 studies, 10 as a primary outcome
- 4
Stroop Color-Word Test15 studies, 7 as a primary outcome
- 5
Symbol Coding11 studies, 4 as a primary outcome
- 6
Category Fluency9 studies, 7 as a primary outcome
- 7
Continuous Performance Test6 studies, 4 as a primary outcome
- 8
Picture Naming Test6 studies, 4 as a primary outcome
- 9
Matrix Reasoning5 studies, 3 as a primary outcome
- 10
Symbol Scan Task5 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 2 | 2 |
| 2016 | 3 | 1 |
| 2017 | 4 | 2 |
| 2018 | 5 | 2 |
| 2019 | 6 | 1 |
| 2020 | 1 | 0 |
| 2021 | 2 | 1 |
| 2022 | 7 | 2 |
| 2023 | 7 | 5 |
| 2024 | 5 | 1 |
| 2025 | 5 | 4 |
| 2026 | 6 | 3 |
Phases and study sizes
By phase
- Phase 1/21 studies, 1 as a primary outcome
- Phase 22 studies, 0 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 41 studies, 0 as a primary outcome
- Not applicable46 studies, 26 as a primary outcome
- Observational9 studies, 2 as a primary outcome
Participants per study
- Not applicable63 median, 35 to 149
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 46 | 63 | 35 to 149 |
When cognitive impairment and decline trials measure it
Latest time point of each outcome
- Within a day7 outcomes, 3 as a primary outcome
- Up to 4 weeks5 outcomes, 3 as a primary outcome
- 1 to 3 months20 outcomes, 14 as a primary outcome
- 3 to 6 months13 outcomes, 2 as a primary outcome
- 6 to 12 months5 outcomes, 1 as a primary outcome
- 1 to 2 years4 outcomes, 4 as a primary outcome
- Over 2 years2 outcomes, 1 as a primary outcome
- No duration given4 outcomes, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
56 of the 60 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting9 studies, 6 as a primary outcome
- Not yet recruiting2 studies, 0 as a primary outcome
- Active, not recruiting4 studies, 3 as a primary outcome
- Completed26 studies, 13 as a primary outcome
- Stopped early2 studies, 2 as a primary outcome
- Status unknown17 studies, 5 as a primary outcome
What they test
- Behavioral20 studies, 12 as a primary outcome
- Drug6 studies, 2 as a primary outcome
- Device9 studies, 4 as a primary outcome
- Dietary supplement12 studies, 9 as a primary outcome
- Procedure1 studies, 0 as a primary outcome
- Diagnostic test3 studies, 1 as a primary outcome
- Other14 studies, 3 as a primary outcome
- None given2 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States17 studies, 12 as a primary outcome
- Spain8 studies, 4 as a primary outcome
- Taiwan6 studies, 2 as a primary outcome
- China4 studies, 1 as a primary outcome
- Netherlands4 studies, 2 as a primary outcome
- France3 studies, 1 as a primary outcome
- South Korea3 studies, 3 as a primary outcome
- Brazil1 studies, 0 as a primary outcome
- Canada1 studies, 0 as a primary outcome
- Denmark1 studies, 0 as a primary outcome
- Egypt1 studies, 0 as a primary outcome
- Germany1 studies, 0 as a primary outcome
19 countries in all. A study with sites in several counts in each; 4 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed cognitive impairment and decline studies that name the Digit Span Test: 12 of 26, 46%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed cognitive impairment and decline studies that name the Digit Span Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 2, 8% | 776, 10% |
| Results on ClinicalTrials.gov only | 5, 19% | 1,139, 14% |
| A results paper only | 5, 19% | 1,711, 22% |
| Neither | 14, 54% | 4,327, 54% |
The 60 studies
60 studies match. 29 name the Digit Span Test in a primary outcome. Median size 66 participants. Median time to the primary outcome: 12 weeks.
Loading 60 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 2 | 2 |
| 2016 | 3 | 1 |
| 2017 | 4 | 2 |
| 2018 | 5 | 2 |
| 2019 | 6 | 1 |
| 2020 | 1 | 0 |
| 2021 | 2 | 1 |
| 2022 | 7 | 2 |
| 2023 | 7 | 5 |
| 2024 | 5 | 1 |
| 2025 | 5 | 4 |
| 2026 | 6 | 3 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 5, other 55. Interventional 51, observational 9.
As a primary outcomeSecondary or other outcomeThe Digit Span Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07891650 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants160 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07802392 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants230 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07766642 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants35 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07751510 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants75 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07564804 | Start2025 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants60 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07531888 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07463391 | Start2026 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants60 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07334366 | Start2025 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07198399 | Start2025 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants35 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07042633 | Start2024 | PhaseObservational | ConditionsCognitive impairment and decline | Participants150 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07011680 | Start2025 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06783465 | Start2025 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06523218 | Start2024 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants50 | Lead sponsorIndustry | StatusStatus unknown | Library tests named
|
| NCT06515106 | Start2023 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06501755 | Start2024 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants36 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06466642 | Start2023 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants43 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06433037 | Start2024 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants164 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06352749 | Start2024 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants120 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06227962 | Start2023 | PhaseObservational | ConditionsCognitive impairment and decline | Participants240 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06183788 | Start2023 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants20 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05990023 | Start2023 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants150 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05854433 | Start2023 | PhaseObservational | ConditionsCognitive impairment and decline | Participants100 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05737498 | Start2023 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants40 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05642169 | Start2022 | PhaseNot applicable | ConditionsCognitive impairment and decline | Participants75 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05640440 | Start2022 | PhaseObservational | ConditionsCognitive impairment and decline | Participants45 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many cognitive impairment and decline trials use the Digit Span Test?
60 registered cognitive impairment and decline studies on ClinicalTrials.gov name it in an outcome measure, 29 of them in a primary outcome: 17% of the condition's 354 studies with a cognitive outcome, against 10% of all of them. It is the 4th most named test in cognitive impairment and decline trials.
Which tests do cognitive impairment and decline trials use with the Digit Span Test?
Verbal Learning (27 studies), the Trail Making Test (25 studies) and Verbal Fluency (17 studies).
When do cognitive impairment and decline trials measure the Digit Span Test?
Half of the primary outcomes that name the Digit Span Test are measured within 12 weeks of the start, and the middle half from 8 weeks to 6 months. 28 primary outcomes give a duration.
How many completed cognitive impairment and decline trials that use the Digit Span Test have reported results?
12 of the 26 completed studies that name it, 46%, have reported results: 7 posted them on ClinicalTrials.gov, 7 have a results paper linked to the registry record, and 2 did both. The other 14 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Digit Span Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.